Clear Labs Launches To Bring Next-Gen Genomics and Transparency to the Food Industry
September 15, 2015
MENLO PARK, Calif. -- Clear Labs, the new standard for molecular food quality, launched from stealth today and announced a $6.5M Series A financing round with participation from Khosla Ventures and Felicis Ventures, among other strategic investors. Clear Labs merges clinical-grade genomic analysis and big data analytics allowing the most respected food brands to gain [...]
September 15, 2015
London UK: Desktop Genetics Ltd (“DTG” or “the Company”), a UK bioinformatics company aiming to revolutionize the way genetic researchers work, announced today that it has secured an investment of £1.37M GBP ($2.15M USD) from a syndicate of VCs and angel investors, including IQ Capital Partners, London Business Angels, the London Co-Investment Fund, Dr Jonathan [...]
Xylem Inc. announces executive leadership appointments
September 15, 2015
RYE BROOK, N.Y. -- Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today announced two significant leadership appointments, which are effective October 1, 2015. Colin Sabol has been named Senior Vice President and President, Analytics and Treatment. In this role, he will lead the global [...]
September 15, 2015
Pleasanton and Redwood City, CA -- Bina Technologies, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), received top honors in the recent DREAM Mutation Calling Challenge, an open crowd-sourced competition and international effort to aggregate prediction algorithms for identifying cancer-associated mutations and rearrangements in next-generation sequencing (NGS) data. The challenge’s winning [...]
September 15, 2015
Watford, UK – Smiths Detection has been awarded a contract by the Spanish Airport Operator (Aena) to equip 24 of its airports with the new IONSCAN 600 explosives trace detector for passenger screening. Almost 300 of the recently launched systems, manufactured by Smiths Detection`s Watford, UK, facility, will be supplied through its Spanish distributor TECOSA. [...]
Easily Automated 3D Cell Culture Growth
September 14, 2015
AMSBIO has announced the launch of Mimetix® 3D cell culture scaffolds that offer significant advantages for a range of applications including regenerative medicine, oncology research, drug discovery and as a unique aligned scaffold for neural growth and investigation**. There is a significant need for more predictive in vitro efficacy assays to reduce both the number [...]
New England Biolabs® Launches NEB TV
September 14, 2015
IPSWICH, MA — Developing exciting ways to re-engineer organisms for novel functionality, like biochemical and protein production, is among the themes discussed in the premier episode of NEB TV, a new monthly video series from New England Biolabs, Inc. (NEB®) that explores cutting-edge research topics and trends in molecular biology. "NEB TV was created to [...]
BioTime, Inc. Agrees to Sell $8.58 Million of Common Shares
September 14, 2015
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT and TASE: BTX) today announced that it has agreed to sell 2,607,401 of its common shares, no par value, at an offering price of $3.29 per share, for a gross purchase price of approximately $8.58 million, to selected investors, including a major shareholder, Broadwood Partners, L.P. (“Broadwood”), in [...]
HORIBA LabSpec 6 software now allows regulatory compliance
September 14, 2015
HORIBA Scientific announces the release of the new ProtectionPlus module for the acclaimed LabSpec 6 Spectroscopy Suite. The fully integrated module seamlessly adds a layer of security and data integrity controls that enable compliant use of HORIBA Raman microscopes within regulated laboratory environments. The ProtectionPlus module offers a configurable module for system security administrators to [...]
AYOXXA Biosystems appoints Dr. Gerald Möller as Chairman of the Board
September 14, 2015
Cologne -- AYOXXA Biosystems GmbH, an international biotechnology company, announced that Dr. Gerald Möller has joined the company's supervisory board as an independent board director and chairman of the board. With 40 years of experience in Pharma, Diagnostics and Biotech, Dr. Möller will guide AYOXXA’s strategic expansion from life science research into disease specific applications, [...]
